AMOYTOP(SH:688278) Zheng Quan Zhi Xing·2025-09-05 11:24Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng (Shenzhen) Law Firm addresses the adjustment of the grant price for the 2024 restricted stock incentive plan of Xiamen TeBao Biological Engineering Co., Ltd. and the granting of reserved restricted stocks to the incentive objects of the plan [1][2][3] Group 1: Adjustment of Grant Price - The grant price for the 2024 restricted stock incentive plan has been adjusted to 39.18 yuan per share from the previous price of 39.80 yuan per share due to a cash dividend distribution of 0.62 yuan per share [8][9][11] - The adjustment was approved by the company's board of directors and is in compliance with the relevant regulations of the Management Measures for Equity Incentives of Listed Companies and the company's incentive plan [7][10] Group 2: Reserved Stock Granting - The company plans to grant 1.2 million shares of restricted stock to 372 eligible incentive objects on September 4, 2025, at the adjusted price of 39.18 yuan per share [11][12] - The granting conditions for the reserved stocks have been met, and the company has fulfilled the necessary approval and authorization processes [10][12] Group 3: Compliance and Disclosure - The company has complied with the necessary legal and regulatory requirements for the adjustment and granting of the incentive plan, ensuring that all actions are in line with the applicable laws and regulations [10][12] - The company is required to continue fulfilling its information disclosure obligations as the incentive plan progresses [12]